Making high-value glycans mainstream
eversyn has raised $1.8M in total funding. The most recent round was Seed. The last funding was announced in January 2024.
eversyn's investors include bmp Ventures, Max Planck Society, EXIST, MPF Start-up Accelerator GmbH.
eversyn is headquartered in Magdeburg, Germany.
Making high-value glycans mainstream
eversyn is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"eversyn — Funding & Investors." VCBacked, January 1, 2024, https://www.vcbacked.co/company/eversyn. Accessed July 22, 2026.
VCBacked. (2024). eversyn — Funding & Investors. Retrieved July 22, 2026, from https://www.vcbacked.co/company/eversyn
{{cite web |title=eversyn — Funding & Investors |url=https://www.vcbacked.co/company/eversyn |website=VCBacked |access-date=July 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated